Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Elife|February 28, 2016
Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolismHongyun Zhao, Lifeng Yang, Joelle Baddour, et al.
NPJ Systems Biology and Applications|July 21, 2017
Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiersTyler J Moss, Zijun Luo, Elena G Seviour, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2010
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypesJoseph H Taube, Jason I Herschkowitz, Kakajan Komurov, et al.
Rice (New York, N.Y.)|February 20, 2019
Marker Assisted Breeding to Develop Multiple Stress Tolerant Varieties for Flood and Drought Prone AreasNitika Sandhu, Shalabh Dixit, B P M Swamy, et al.
Molecular Systems Biology|May 7, 2014
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancerLifeng Yang, Tyler Moss, Lingegowda S Mangala, et al.
Plants (Basel, Switzerland)|March 10, 2022
Multiparent-Derived, Marker-Assisted Introgression Lines of the Elite Indian Rice Cultivar, 'Krishna Hamsa' Show Resistance against Bacterial Blight and Blast and Tolerance to DroughtJyothi Badri, Gandhudi Lakshmidevi, L R K JaiVidhya, et al.
Cancers|September 9, 2022
Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian CarcinomaElaine Stur, Emine Bayraktar, Graziela Zibetti Dal Molin, et al.
Molecular Cancer Therapeutics|November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.
Oncogene|February 3, 2015
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancerE G Seviour, V Sehgal, Y Lu, et al.
Molecular Cancer Therapeutics|September 29, 2021
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse ModelsKatelyn F Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, et al.
Pageof 9